Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Immunogen (IMGN)
NASDAQ:IMGN
Holding IMGN?
Track your performance easily
IMGN Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$3.61 - $31.25
Previous Close$31.23
Volume48.61M
Average Volume (3M)9.63M
Market Cap
$8.72B
Enterprise Value$8.20B
Total Cash (Recent Filing)$605.50M
Total Debt (Recent Filing)$84.33M
Price to Earnings (P/E)―
Beta0.66
Next Earnings
May 03, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.30
Shares Outstanding266,264,274
10 Day Avg. Volume9,635,137
30 Day Avg. Volume9,633,123
Standard Deviation0.30
R-Squared0.05
Alpha0.05
Financial Highlights & Ratios
Price to Book (P/B)14.15
Price to Sales (P/S)73.09
Price to Cash Flow (P/CF)708.20
P/FCF Ratio372.20
Enterprise Value/Market CapN/A
Enterprise Value/Revenue42.57
Enterprise Value/Gross Profit7.46K
Enterprise Value/Ebitda-180.29
Forecast
1Y Price Target
$31.10Price Target Upside-0.42% Downside
Rating ConsensusHold
Number of Analyst Covering9
ImmunoGen News
PremiumCompany Announcements
ImmunoGen Finalizes Merger, Amends Operations, and Delists Shares
PremiumPress Releases
AbbVie Completes Acquisition of ImmunoGen
PremiumCompany Announcements
ImmunoGen Set to Merge with AbbVie, Awaiting Final ApprovalPremiumPre-Earnings
Is IMGN a Buy, Before Earnings?
PremiumCompany Announcements
Immunogen Shareholders Approve Merger with AbbVie Inc.
PremiumCompany Announcements
ImmunoGen’s Merger with AbbVie Awaits Shareholder ApprovalRisk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
IMGN FAQ
What was Immunogen’s price range in the past 12 months?
Immunogen lowest stock price was $3.60 and its highest was $31.25 in the past 12 months.
What is Immunogen’s market cap?
Currently, no data Available
When is Immunogen’s upcoming earnings report date?
Immunogen’s upcoming earnings report date is May 03, 2024 which is 204 days ago.
How were Immunogen’s earnings last quarter?
Currently, no data Available
Is Immunogen overvalued?
According to Wall Street analysts Immunogen’s price is currently Overvalued.
Does Immunogen pay dividends?
Immunogen does not currently pay dividends.
What is Immunogen’s EPS estimate?
Immunogen’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Immunogen have?
Immunogen has 149,695,000 shares outstanding.
What happened to Immunogen’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Immunogen?
Among the largest hedge funds holding Immunogen’s share is RA Capital Management. It holds Immunogen’s shares valued at 704M.
---
ImmunoGen Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
$31.10 (-0.42% Downside)
$31.10 (-0.42% Downside)
Blogger Sentiment
Bullish
IMGN Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 7.7M Shares
Last Quarter.
Last Quarter.
Insider Transactions
Bought Shares
Worth $159.6K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 2.7%
Last 30 Days ▼ 5.0%
Last 30 Days ▼ 5.0%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Positive
20 days / 200 days
Momentum
690.63%
12-Months-Change
Fundamentals
Return on Equity
-19.88%
Trailing 12-Months
Asset Growth
129.13%
Trailing 12-Months
Company Description
Immunogen
ImmunoGen, Inc. is a biotechnology company, which engages in discovering and developing antibody-drug conjugate therapies that meaningfully improve the lives of people with cancer. Its product candidates include Mirvetuximab soravtansine, Coltuximab ravtansine, IMGN7779 and IMGN632. The company was founded in March 1981 and is headquartered in Waltham, MA.
---
IMGN Earnings Call
Q3 2023
0:00 / 0:00
---
IMGN Stock 12 Month Forecast
Average Price Target
$31.10
▼(-0.42% Downside)
Technical Analysis
Best Analysts Covering IMGN
1 Year
1 Year Success Rate
8/9 ratings generated profit
1 Year Average Return
+69.12%
reiterated a buy rating a year ago
Copying Boris Peaker's trades and holding each position for 1 Year would result in 88.89% of your transactions generating a profit, with an average return of +69.12% per trade.
---